The stock of InMed Pharmaceuticals Inc (NASDAQ:INM) last traded at $0.29, up 7.05% from the previous session.
INM stock price is now 13.60% away from the 50-day moving average and -8.19% away from the 200-day moving average. The market capitalization of the company currently stands at $0.97M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
In other news, MANCINI ALEXANDRA DIANE JANET, Consultant sold 240 shares of the company’s stock on Jul 31 ’24. The stock was sold for $42 at an average price of $0.18. Upon completion of the transaction, the Consultant now directly owns 0 shares in the company, valued at $0.0. An SEC document containing details of the transaction can be found on the SEC’s website. On Feb 21 ’24, Director HULL ANDREW bought 37,500 shares of the business’s stock. A total of $14,625 was incurred on buying the stock at an average price of $0.39. This leaves the insider owning 38,258 shares of the company worth $11094.82. A total of 1.06% of the company’s stock is owned by insiders.
During the past 12 months, InMed Pharmaceuticals Inc has had a low of $0.12 and a high of $2.08. As of last week, the company has a debt-to-equity ratio of 0.10, a current ratio of 6.58, and a quick ratio of 5.80. The fifty day moving average price for INM is $0.25612 and a two-hundred day moving average price translates $0.31546 for the stock.
The latest earnings results from InMed Pharmaceuticals Inc (NASDAQ: INM) was released for 2024-03-31. The net profit margin was -108.01% and return on equity was -51.73% for INM. The company reported revenue of $1.17 million for the quarter, compared to $1.03 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 13.44 percent.
